Vitro Biopharma, Inc. Employee Directory

Biotechnology ResearchColorado, United States11-50 Employees

Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. AlloRx Stem Cell therapy is intended to be an “off-the-shelf” commercialized product that is stored frozen and available for on demand use. Our pipeline includes four core development programs. We intend to initiate our clinical trials for Long COVID and PTHS in late 2022 or 2023. In addition, we are also currently focused on our pre clinical development programs for MS and Lupus/SLE.

Our research products include:
a) Cell Culture Media 
-We offer various formulations of MSCs and primary cell cultures with numerous competitive advantages.
b) Various Cell Lines
-Our cell lines include Umbilical Cord Blood derived MSCs, Adipose derived MSCs, Fluorescent Labeled MSCs, Cancer Associated Fibroblasts (CAFs), and Differentiated MSCs
c) Brain-Grow Technologies
-Neurological and Inflammatory Biomarker Profiling and Nutraceutical Recovery Packages

Sign up for free to view info

Company overview Email format